Baseline SUV Range for Liver and Blood Pool in Patients Undergoing F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

dc.contributor.authorYasemin PARLAK
dc.contributor.authorDidem GÖKSOY
dc.contributor.authorGözde MÜTEVELİZADE
dc.contributor.authorGül GÜMÜŞER
dc.contributor.authorElvan SAYIT
dc.date.accessioned2024-07-24T09:09:55Z
dc.date.available2024-07-24T09:09:55Z
dc.date.issued2019
dc.description.abstractIntroduction: The aim of the study was to define the baselineSUVmax range in the liver and blood pool of patients undergoingfluorodeoxyglucose-positron emission tomography/computedtomography (FDG-PET/CT) imaging.Methods: Five hundred and thirty-one patients (264 females,267 males; mean age: 59.6±13.4 years) who were admittedto our department for PET/CT imaging before treatmentwere included in the study. Patient preparation, acquisitionparameters and reconstruction protocols were standardized forall patients prior to PET/CT imaging. The mean serum glucoselevels and mean age of the patients were calculated. Thesepatients were divided into 10 groups as esophagus, stomach,colon, rectum, larynx, lung, breast, endometrium, ovariancancers and lymphoma. 2D region of interests were plotted tocalculate the mean SUV values in the right lobe of the liver andthe aortic arch for the blood pool.Results: Normal Gaussian distributions of mean SUV changesfor liver and blood pool were obtained. Mean SUVmax and SUVmeanvalues for liver were 2.73±0.22 and 2.34±0.16, respectively,and 1.80±0.2 and 1.57±0.14 for blood pool, respectively.Conclusion: It was concluded that the obtained SUV rangesmay provide ease of application in the clinic in evaluatingqualitative tumor response and comparing tumor/backgroundratios in cancer patients.
dc.identifier.DOI-ID10.4274/imj.galenos.2019.43255
dc.identifier.issn2619-9793
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/22497
dc.language.isoeng
dc.subject[Fen > Tıp > Tıbbi Araştırmalar Deneysel, Fen > Tıp > Genel ve Dahili Tıp]
dc.titleBaseline SUV Range for Liver and Blood Pool in Patients Undergoing F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
dc.typeAraştırma Makalesi

Files